Evidence map›Paper›PMID 34197055›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2021

Multimodal Imaging with NanoGd Reveals Spatiotemporal Features of Neuroinflammation after Experimental Stroke.

Violaine Hubert, Ines Hristovska, Szilvia Karpati, Sarah Benkeder, Arindam Dey, Chloé Dumot, Camille Amaz, Naura Chounlamountri, Chantal Watrin, Jean-Christophe Comte and 9 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Violaine HubertUniv-Lyon, IRIS Team, CarMeN Laboratory, Inserm U1060, INRA U1397, INSA Lyon, Université Claude Bernard Lyon 1, Groupement Hospitalier Est, 59 bd. Pinel, Bron, 69500, France.ORCID 0000-0001-5656-5690
Ines HristovskaSYNATAC Team, Institut NeuroMyoGène, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Faculté de Médecine et de Pharmacie, 8 avenue Rockefeller, Lyon, 69008, France.
Szilvia KarpatiUniversité de Lyon, École Normale Supérieure de Lyon, CNRS UMR 5182, Université Claude Bernard Lyon 1, Laboratoire de Chimie, Lyon, F69342, France.
Sarah BenkederSYNATAC Team, Institut NeuroMyoGène, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Faculté de Médecine et de Pharmacie, 8 avenue Rockefeller, Lyon, 69008, France.
Arindam DeyInstitut pour l'Avancée des Biosciences, Centre de Recherche UGA / Inserm U 1209 / CNRS UMR 5309, Site Santé - Allée des Alpes, La Tronche, 38700, France.ORCID 0000-0002-0591-3314
Chloé DumotUniv-Lyon, IRIS Team, CarMeN Laboratory, Inserm U1060, INRA U1397, INSA Lyon, Université Claude Bernard Lyon 1, Groupement Hospitalier Est, 59 bd. Pinel, Bron, 69500, France.
Camille AmazClinical Investigation Center, Hospices Civils de Lyon, Louis Pradel Hospital, 28 avenue Doyen Lépine, Bron, 69500, France.
Naura ChounlamountriSYNATAC Team, Institut NeuroMyoGène, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Faculté de Médecine et de Pharmacie, 8 avenue Rockefeller, Lyon, 69008, France.
Chantal WatrinSYNATAC Team, Institut NeuroMyoGène, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Faculté de Médecine et de Pharmacie, 8 avenue Rockefeller, Lyon, 69008, France.
Jean-Christophe ComteFORGETTING Team, Lyon Neuroscience Research Center (CRNL), CNRS UMR5292, INSERM U1028, Université Claude Bernard Lyon 1, Centre Hospitalier Le Vinatier - Bâtiment 462 - Neurocampus Michel Jouvet, 95 boulevard Pinel, Bron, 69675, France.
Fabien ChauveauUniversité de Lyon, Lyon Neuroscience Research Center (CRNL), CNRS UMR5292, INSERM U1028, Université Claude Bernard Lyon 1, Groupement Hospitalier Est - CERMEP, 59 bd Pinel, Bron Cedex, 69677, France.ORCID 0000-0002-4177-741X
Emmanuel BrunSynchrotron Radiation for Biomedical Research (STROBE), UA7 INSERM, Université Grenoble Alpes, Medical Beamline at the European Synchrotron Radiation Facility, 71 Avenue des Martyrs, Grenoble Cedex 9, 38043, France.ORCID 0000-0002-0332-4903
Patrice MarcheInstitut pour l'Avancée des Biosciences, Centre de Recherche UGA / Inserm U 1209 / CNRS UMR 5309, Site Santé - Allée des Alpes, La Tronche, 38700, France.ORCID 0000-0002-8930-9340
Fréderic LerougeUniversité de Lyon, École Normale Supérieure de Lyon, CNRS UMR 5182, Université Claude Bernard Lyon 1, Laboratoire de Chimie, Lyon, F69342, France.ORCID 0000-0003-2909-527X
Stéphane ParolaUniversité de Lyon, École Normale Supérieure de Lyon, CNRS UMR 5182, Université Claude Bernard Lyon 1, Laboratoire de Chimie, Lyon, F69342, France.ORCID 0000-0001-7560-988X
Yves BerthezèneUniv-Lyon, Creatis Laboratory, CNRS UMR5220, Inserm U1044, INSA Lyon, Villeurbanne Cedex, 69621, France.
Thomas Vorup-JensenDepartment of Biomedicine, Biophysical Immunology Laboratory, Aarhus University, Aarhus C, DK-8000, Denmark.ORCID 0000-0002-4140-6563
Olivier PascualSYNATAC Team, Institut NeuroMyoGène, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Faculté de Médecine et de Pharmacie, 8 avenue Rockefeller, Lyon, 69008, France.ORCID 0000-0002-5730-9880
Marlène WiartUniv-Lyon, IRIS Team, CarMeN Laboratory, Inserm U1060, INRA U1397, INSA Lyon, Université Claude Bernard Lyon 1, Groupement Hospitalier Est, 59 bd. Pinel, Bron, 69500, France.ORCID 0000-0003-0326-7002
Université Claude Bernard Lyon 1 · FRCentre National de la Recherche Scientifique · FRAarhus University · DKHospices Civils de Lyon · FRInserm · FR

Funding

Broad-based Collaboratives to Address Health DisparitiesR24MD001094 · NIMHD · UNIVERSITY OF SOUTH ALABAMA · PI CROOK, ERROL D · 2004 to 2006
$1.2M
ESRF MD1094French national research agencyNanoBrain ANR-15-CE18-0026-01NIMHD NIH HHS R24 MD001094RHU MARVELOUS ANR16-RHUS-0009
6 · The paper itself

Abstract

The purpose of this study is to propose and validate a preclinical in vivo magnetic resonance imaging (MRI) tool to monitor neuroinflammation following ischemic stroke, based on injection of a novel multimodal nanoprobe, NanoGd, specifically designed for internalization by phagocytic cells. First, it is verified that NanoGd is efficiently internalized by microglia in vitro. In vivo MRI coupled with intravenous injection of NanoGd in a permanent middle cerebral artery occlusion mouse model results in hypointense signals in the ischemic lesion. In these mice, longitudinal two-photon intravital microscopy shows NanoGd internalization by activated CX3CR1-GFP/+ cells. Ex vivo analysis, including phase contrast imaging with synchrotron X-ray, histochemistry, and transmission electron microscopy corroborate NanoGd accumulation within the ischemic lesion and uptake by immune phagocytic cells. Taken together, these results confirm the potential of NanoGd-enhanced MRI as an imaging biomarker of neuroinflammation at the subacute stage of ischemic stroke. As far as it is known, this work is the first to decipher the working mechanism of MR signals induced by a nanoparticle passively targeted at phagocytic cells by performing intravital microscopy back-to-back with MRI. Furthermore, using a gadolinium-based rather than an iron-based contrast agent raises future perspectives for the development of molecular imaging with emerging computed tomography technologies.

Indexed as

GadoliniumAnimalsBrainDisease Models, AnimalMagnetic Resonance ImagingMiceMicroscopy, ElectronMultimodal ImagingNanotechnologyNeuroinflammatory DiseasesStrokeGadoliniumintravital two-photon microscopymagnetic resonance imagingmicroglia/macrophagemultimodal nanoprobeneuroinflammationstroke

Identifiers

PMID34197055
PMCPMC8425862
OpenAlexW3175670306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.